Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

38.95
+3.8210.86%
Volume:49.14K
Turnover:1.91M
Market Cap:153.39M
PE:-11.55
High:41.66
Open:35.01
Low:33.99
Close:35.14
52wk High:44.00
52wk Low:14.00
Shares:3.94M
Float Shares:2.84M
Volume Ratio:2.38
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3732
EPS(LYR):-3.1991
ROE:-64.17%
ROA:-26.12%
PB:7.20
PE(LYR):-12.18

Loading ...

vTv Therapeutics Presents at TD Cowen Health Care Conference

Reuters
·
Feb 13

vTv Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Feb 13

Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
Feb 03

vTv Therapeutics expanded its license agreement with Newsoara Biopharma

TIPRANKS
·
Feb 02

vTv Therapeutics Inc - Amended License Includes $50 Mln Development and $65 Mln Sales Milestones

THOMSON REUTERS
·
Feb 02

vTv Therapeutics Inc - to Receive $20 Mln Upfront Payment From Newsoara

THOMSON REUTERS
·
Feb 02

vTv Therapeutics Amends License Agreement With Newsoara Biopharma Co. Ltd. for Pde4 Inhibitor, HPP737

THOMSON REUTERS
·
Feb 02

vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737

GlobeNewswire
·
Feb 02

vTv Therapeutics Inc : Btig Raises Target Price to $49 From $40

THOMSON REUTERS
·
Jan 27

vTv Therapeutics Is Maintained at Buy by BTIG

Dow Jones
·
Jan 27

Analysts’ Top Healthcare Picks: OKYO Pharma Limited Sponsored ADR (OKYO), vTv Therapeutics (VTVT)

TIPRANKS
·
Jan 24

vTv Therapeutics Initiated at Buy by Roth Capital

Dow Jones
·
Jan 23

vTv Therapeutics initiated with a Buy at Roth Capital

TIPRANKS
·
Jan 23

vTv Therapeutics: Late-Stage Cadisegliatin Data, Differentiated Mechanism, and Partnered T2D Expansion Underpin Buy Rating and $40 Target

TIPRANKS
·
Jan 14

TD Cowen Initiates vTv Therapeutics at Buy With $67 Price Target

MT Newswires Live
·
Jan 05

This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Benzinga_recent_news
·
Jan 05

vTv Therapeutics Initiated at Buy by TD Cowen

Dow Jones
·
Jan 05

vTv Therapeutics Lowers Stockholder Meeting Quorum to 33.4%

Reuters
·
Dec 20, 2025

vTv Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Dec 19, 2025

vTv Therapeutics Inc : H.c. Wainwright Raises Target Price to $47 From $36

THOMSON REUTERS
·
Dec 19, 2025